Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial
In: The Lancet Microbe, Jg. 3 (2022), Heft 5, S. e336-e347
academicJournal
Zugriff:
Titel: |
Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial
|
---|---|
Autor/in / Beteiligte Person: | Stone, Will ; Mahamar, Almahamoudou ; Smit, Merel J ; Sanogo, Koualy ; Sinaba, Youssouf ; Niambele, Sidi M ; Sacko, Adama ; Keita, Sekouba ; Dicko, Oumar M ; Diallo, Makonon ; Maguiraga, Seydina O ; Samake, Siaka ; Attaher, Oumar ; Lanke, Kjerstin ; ter Heine, Rob ; Bradley, John ; McCall, Matthew B B ; Issiaka, Djibrilla ; Traore, Sekou F ; Bousema, Teun ; Drakeley, Chris ; Dicko, Alassane ; Bill & Melinda Gates Foundation |
Link: | |
Zeitschrift: | The Lancet Microbe, Jg. 3 (2022), Heft 5, S. e336-e347 |
Veröffentlichung: | Elsevier BV, 2022 |
Medientyp: | academicJournal |
ISSN: | 2666-5247 |
DOI: | 10.1016/s2666-5247(21)00356-6 |
Schlagwort: |
|
Sonstiges: |
|